Featured Research

from universities, journals, and other organizations

New study identifies significance of co-infection in disease control

Date:
January 9, 2013
Source:
Cardiff University
Summary:
Becoming infected with one parasite could change your chances of becoming infected with another according to new research. The new study analyses data from school aged children in Tanzania infected with the most common forms of worms.

Becoming infected with one parasite could change your chances of becoming infected with another according to new University research.

A new study led by the School of Biosciences analyses data from school-aged children in Tanzania infected with the most common forms of worms. It has found that infection by one parasitic species actually changes the risk of catching another, over and above other risk factors.

The study is the first to look at the significance of infection with one disease as a risk for further infections (i.e. co-infection). The findings could help us better understand the importance of co-infection as a risk, and could help inform disease control strategies.

Traditionally, co-infection, where the person or population of people has more than one parasite species in it, has been seen as a result of other risks. For example, if people in a population have two different parasites more often than expected by chance, then it is often thought that these two parasites must have been picked up at the same time because of where they are in the environment (co-exposure) and that the place the person lives or plays therefore is the cause of this co-infection (in other words a person's environment would be the risk factor).

Dr Joanne Lello, School of Biosciences and lead author on the study said: "Infectious diseases are among the most important causes of childhood mortality and morbidity in the developing world. Understanding what drives an individual's infections is essential if effective disease-control strategies are to be developed. We know there are many possible risk factors associated with an individual's infections, including their physical environment, genetics, behaviour and demographic factors, but a comparatively understudied risk factor for infection with one organism is co-infection with a second species."

By studying the associations between the four most prevalent infections among school-aged children in Tanzania -- Ascaris lumbricoides, Trichuris trichiura, hookworm and self-reported fever -- Dr Lello and colleagues (from the Universities of Bristol and Basel (Switzerland) and from the Ministry of Health in Tanzania), found that co-infection cannot be explained away as a simple coincidence that is due, for example by co-exposure in the environment.

They found that co-infection is itself a very important risk factor, and sometimes more important than any of the other risks considered, such as a child's living conditions, behaviour and sex. However, the risk does not always increase. They also find that infection with one parasite species can sometimes be associated with a lower risk of infection with a second parasite species.

Explaining the significance of these findings Dr Lello, said: "We were able to include in our statistical model many different things which have been identified as risks before, for example a child's living conditions, behaviour, sex and so on. As such we could tell that the co-infections were not just caused by these 'other' risks and importantly we could also tell how much difference every risk made compared to one another. This showed us that co-infection was important for all the diseases we looked at and often it was more important than most of these 'other' risks.

"When medics and government design programmes to control diseases they use their knowledge of what things change the probability of becoming infected, called risk factors. If we miss out important risk factors then control programmes are unlikely to work effectively and resources can be wasted targeting the wrong things. Knowing that co-infection is a major risk factor is therefore really important and our study demonstrates this for the first time.

"Although our study was conducted on children in Tanzania, co-infection with different parasites occurs everywhere and so the principle that one parasite can change the probability of being infected with another has wide implications."


Story Source:

The above story is based on materials provided by Cardiff University. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Lello, S. Knopp, K. A. Mohammed, I. S. Khamis, J. Utzinger, M. E. Viney. The relative contribution of co-infection to focal infection risk in children. Proceedings of the Royal Society B: Biological Sciences, 2013; 280 (1754): 20122813 DOI: 10.1098/rspb.2012.2813

Cite This Page:

Cardiff University. "New study identifies significance of co-infection in disease control." ScienceDaily. ScienceDaily, 9 January 2013. <www.sciencedaily.com/releases/2013/01/130109105934.htm>.
Cardiff University. (2013, January 9). New study identifies significance of co-infection in disease control. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/01/130109105934.htm
Cardiff University. "New study identifies significance of co-infection in disease control." ScienceDaily. www.sciencedaily.com/releases/2013/01/130109105934.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins